Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 14 studies | 41% ± 18% | |
| classical monocyte | 11 studies | 25% ± 11% | |
| adipocyte | 10 studies | 45% ± 16% | |
| ciliated cell | 9 studies | 30% ± 12% | |
| macrophage | 9 studies | 25% ± 10% | |
| type I pneumocyte | 8 studies | 29% ± 10% | |
| type II pneumocyte | 8 studies | 45% ± 16% | |
| non-classical monocyte | 7 studies | 27% ± 13% | |
| enterocyte | 7 studies | 59% ± 18% | |
| plasmacytoid dendritic cell | 7 studies | 25% ± 8% | |
| goblet cell | 6 studies | 37% ± 14% | |
| endothelial cell | 6 studies | 22% ± 4% | |
| alveolar macrophage | 5 studies | 24% ± 4% | |
| basal cell | 5 studies | 28% ± 14% | |
| progenitor cell | 5 studies | 28% ± 5% | |
| monocyte | 5 studies | 23% ± 5% | |
| club cell | 4 studies | 20% ± 6% | |
| respiratory goblet cell | 4 studies | 22% ± 8% | |
| secretory cell | 4 studies | 26% ± 5% | |
| kidney loop of Henle epithelial cell | 4 studies | 31% ± 14% | |
| kidney distal convoluted tubule epithelial cell | 4 studies | 31% ± 16% | |
| transit amplifying cell | 4 studies | 20% ± 4% | |
| fibroblast | 4 studies | 22% ± 5% | |
| hepatocyte | 4 studies | 37% ± 27% | |
| dendritic cell | 4 studies | 34% ± 10% | |
| deuterosomal cell | 3 studies | 22% ± 6% | |
| ionocyte | 3 studies | 21% ± 1% | |
| conventional dendritic cell | 3 studies | 36% ± 9% | |
| hematopoietic precursor cell | 3 studies | 32% ± 10% | |
| enteroendocrine cell | 3 studies | 27% ± 3% | |
| myeloid cell | 3 studies | 26% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 4770.84 | 328 / 328 | 99% | 237.96 | 177 / 178 |
| thymus | 100% | 3466.13 | 652 / 653 | 99% | 177.02 | 601 / 605 |
| intestine | 100% | 4525.44 | 962 / 966 | 99% | 295.95 | 523 / 527 |
| stomach | 99% | 2697.60 | 357 / 359 | 99% | 261.70 | 284 / 286 |
| prostate | 100% | 2429.33 | 244 / 245 | 99% | 85.36 | 496 / 502 |
| esophagus | 100% | 3126.73 | 1440 / 1445 | 98% | 167.71 | 179 / 183 |
| skin | 100% | 3007.52 | 1805 / 1809 | 98% | 155.20 | 461 / 472 |
| liver | 100% | 15461.47 | 226 / 226 | 97% | 210.71 | 395 / 406 |
| lung | 99% | 4440.75 | 574 / 578 | 97% | 177.33 | 1126 / 1155 |
| bladder | 100% | 2347.33 | 21 / 21 | 97% | 208.11 | 487 / 504 |
| uterus | 99% | 1906.58 | 168 / 170 | 97% | 151.77 | 447 / 459 |
| kidney | 100% | 4048.19 | 89 / 89 | 96% | 88.42 | 863 / 901 |
| breast | 99% | 17119.02 | 456 / 459 | 93% | 105.03 | 1044 / 1118 |
| ovary | 81% | 1027.88 | 145 / 180 | 98% | 132.39 | 422 / 430 |
| adrenal gland | 99% | 2466.14 | 256 / 258 | 55% | 65.35 | 126 / 230 |
| eye | 0% | 0 | 0 / 0 | 100% | 423.25 | 80 / 80 |
| spleen | 100% | 2686.80 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 173.11 | 1 / 1 |
| adipose | 100% | 23122.66 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 98.17 | 44 / 45 |
| heart | 98% | 3503.34 | 841 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 83.61 | 27 / 29 |
| peripheral blood | 89% | 3344.17 | 831 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 81% | 2138.65 | 1082 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 77% | 1307.91 | 618 / 803 | 0% | 0 | 0 / 0 |
| brain | 18% | 202.87 | 467 / 2642 | 23% | 11.18 | 165 / 705 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006654 | Biological process | phosphatidic acid biosynthetic process |
| GO_0006644 | Biological process | phospholipid metabolic process |
| GO_0001961 | Biological process | positive regulation of cytokine-mediated signaling pathway |
| GO_0019432 | Biological process | triglyceride biosynthetic process |
| GO_0001819 | Biological process | positive regulation of cytokine production |
| GO_0009410 | Biological process | response to xenobiotic stimulus |
| GO_0008544 | Biological process | epidermis development |
| GO_0016024 | Biological process | CDP-diacylglycerol biosynthetic process |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0035579 | Cellular component | specific granule membrane |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0003841 | Molecular function | 1-acylglycerol-3-phosphate O-acyltransferase activity |
| Gene name | AGPAT2 |
| Protein name | 1-acyl-sn-glycerol-3-phosphate acyltransferase (EC 2.3.1.51) 1-acyl-sn-glycerol-3-phosphate acyltransferase beta (EC 2.3.1.51) (1-acylglycerol-3-phosphate O-acyltransferase 2) (1-AGP acyltransferase 2) (1-AGPAT 2) (Lysophosphatidic acid acyltransferase beta) (LPAAT-beta) 1-acylglycerol-3-phosphate O-acyltransferase (EC 2.3.1.51) |
| Synonyms | |
| Description | FUNCTION: Converts 1-acyl-sn-glycerol-3-phosphate (lysophosphatidic acid or LPA) into 1,2-diacyl-sn-glycerol-3-phosphate (phosphatidic acid or PA) by incorporating an acyl moiety at the sn-2 position of the glycerol backbone. . FUNCTION: Converts 1-acyl-sn-glycerol-3-phosphate (lysophosphatidic acid or LPA) into 1,2-diacyl-sn-glycerol-3-phosphate (phosphatidic acid or PA) by incorporating an acyl moiety at the sn-2 position of the glycerol backbone. . |
| Accessions | Q8WUW2 Q96IS9 ENST00000371696.7 [O15120-1] O15120 ENST00000371694.7 [O15120-2] |